Mexico - North America Peptide Therapeutics Market Size & Outlook

Name: Mexico - North America Peptide Therapeutics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The peptide therapeutics market in Mexico - North America is expected to reach a projected revenue of US$ 2,984.1 million by 2033. A compound annual growth rate of 9.2% is expected of Mexico - North America peptide therapeutics market from 2026 to 2033.

Mexico peptide therapeutics application outlook (Revenue, USD million, 2021-2033)
- Cancer
- Metabolic disorders
- Cardiovascular disorders
- Respiratory disorders
- Gastrointestinal disorders
- Infectious disease
- Pain
- Dermatological disorders
- Neurological disorders
- Renal disorders
- Others
Mexico peptide therapeutics type outlook (Revenue, USD million, 2021-2033)
- Generic
- Innovative
Mexico peptide therapeutics type of manufacturers outlook (Revenue, USD million, 2021-2033)
- Inhouse
- Outsourced
Mexico peptide therapeutics route of administration outlook (Revenue, USD million, 2021-2033)
- Parenteral Route
- Oral Route
- Pulmonary
- Mucosal
- Others
Mexico peptide therapeutics synthesis technology outlook (Revenue, USD million, 2021-2033)
- Recombinant DNA Technology
- Solid-Phase Peptide Synthesis (SPPS)
- Hybrid
- Liquid-Phase Peptide Synthesis (LPPS)
- Others
Mexico peptide therapeutics type of manufacturer outlook (Revenue, USD million, 2021-2033)
- Inhouse
- Outsourced

Mexico - North America Peptide Therapeutics Market Size & Outlook

Sign up - it's easy, and free!